Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of High-Dose Quetiapine in Patients With Persistent Symptoms of Schizophrenia or Schizoaffective Disorder PDF $40.00
$40.00
× Placeholder The Epidemiology of Chronic Major Depressive Disorder and Dysthymic Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions PDF $40.00
$40.00
× Placeholder Pharmacoeconomic Analysis of Sertraline Treatment of Depression in Patients With Unstable Angina or a Recent Myocardial Infarction PDF $40.00
$40.00
× Placeholder Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 1: Predictors of Clinical Response in Fluoxetine-Resistant Depression PDF $40.00
$40.00
× Placeholder The Safety of Olanzapine in Adolescents With Schizophrenia or Bipolar I Disorder: A Pooled Analysis of 4 Clinical Trials PDF $40.00
$40.00
× Placeholder A Post Hoc Analysis of the Effect of Nightly Administration of Eszopiclone and a Selective Serotonin Reuptake Inhibitor in Patients With Insomnia and Anxious Depression PDF $40.00
$40.00
× Placeholder Analyses of Treatment-Emergent Mania With Olanzapine/Fluoxetine Combination in the Treatment of Bipolar Depression PDF $40.00
$40.00
× Placeholder Relapse of Aggressive and Disruptive Behavior in Mentally Retarded Adults Following Antipsychotic Drug Withdrawal Predicts Psychotropic Drug Use a Decade Later PDF $40.00
$40.00
× Placeholder Impact of Deleting 5 DSM-IV Personality Disorders on Prevalence, Comorbidity, and the Association Between Personality Disorder Pathology and Psychosocial Morbidity PDF $40.00
$40.00
× Placeholder Demographics, Clinical Characteristics, and Treatment of Aggressive Patients Admitted to the Acute Behavioral Unit of a Community General Hospital: A Prospective Observational Study PDF $40.00
$40.00
× Placeholder Effectiveness and Safety of Vagus Nerve Stimulation for Severe Treatment-Resistant Major Depression in Clinical Practice After FDA Approval: Outcomes at 1 Year PDF $40.00
$40.00
× Placeholder Bridging Community Mental Health and Primary Care to Improve Medication Monitoring and Outcomes for Patients With Mental Illness Taking Second-Generation Antipsychotics—HDC/DFMC Bridge Project, Phase 1: Group Concept Mapping PDF $40.00
$40.00
× Placeholder Bridging Community Mental Health and Primary Care to Improve Medication Monitoring and Outcomes for Patients With Mental Illness Taking Second-Generation Antipsychotics—Phase 2: Quality Improvement Initiative Over 15 Months PDF $40.00
$40.00
× Placeholder Off-Label Use of Antidepressant, Anticonvulsant, and Antipsychotic Medications Among Georgia Medicaid Enrollees in 2001. PDF $40.00
$40.00
× Placeholder Impact of a US Food and Drug Administration Drug Safety Communication on Zolpidem Dosing: An Observational Retrospective Cohort PDF $40.00
$40.00
× Placeholder Impact of the Abbreviated Suicide Crisis Syndrome Checklist on Clinical Decision Making in the Emergency Department PDF $40.00
$40.00
× Placeholder Efficacy and Response Time to Sertraline Versus Fluoxetine in the Treatment of Unipolar Major Depressive Disorder PDF $40.00
$40.00
× Placeholder Psychiatrists' and Nonpsychiatrist Physicians' Reported Use of the DSM-IV Criteria for Major Depressive Disorder PDF $40.00
$40.00
× Placeholder Weaning From Exogenous Sedation in the Era of COVID-19 Infection: Recommendations for Sedation and Its Discontinuation PDF $40.00
$40.00
× Placeholder The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled Study PDF $40.00
$40.00
× Placeholder A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of the Acute Antisuicidal and Antidepressant Effects of Intranasal (R,S)-Ketamine in Severe Unipolar and Bipolar Depression With and Without Comorbid Alcohol Use Disorder PDF $40.00
$40.00
× Placeholder Efficacy and Tolerability of Quetiapine in the Treatment of Borderline Personality Disorder: A Pilot Study. PDF $40.00
$40.00
× Placeholder Prescribing Topiramate in Patients With Borderline Personality Disorder and a History of Anorexia Nervosa: A Case Report PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $920.00
Total $920.00
Proceed to checkout

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe